Sample size determination for a specific region in a multiregional trial

Journal of Biopharmaceutical Statistics

Volumn 20, Issue 4, 2010, Pages 870-885

  Ko, Feng Shou ^a   Tsou, Hsiao Hui ^a   Liu, Jen Pei ^a,b   Hsiao, Chin Fu ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Bridging Study; Consistent Trend; Multiregional Trial

Indexed keywords

DRUG; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; ATHEROSCLEROSIS; CLINICAL STUDY; CORONARY ARTERY DISEASE; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; GEOGRAPHIC DISTRIBUTION; HEALTH CARE PLANNING; HUMAN; HYPERCHOLESTEROLEMIA; MATHEMATICAL COMPUTING; PLACEBO EFFECT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROBABILITY; SAMPLE SIZE; STATISTICAL MODEL; THEORETICAL MODEL;

ALGORITHMS; ANTICHOLESTEREMIC AGENTS; ATHEROSCLEROSIS; ETHNIC GROUPS; HUMANS; HYPERCHOLESTEROLEMIA; INTERNATIONALITY; MODELS, STATISTICAL; MULTICENTER STUDIES AS TOPIC; PROBABILITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SAMPLE SIZE;

EID: 77952914790     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543401003618900     Document Type: Article

References (21)

1. Chow, S. C., Shao, J., Hu, O. Y. P. (2002). Assessing sensitivity and similarity in bridging studies. Journal of Biopharmaceutical Statistics 12:385-400.
2. Chung-Stein, C., Anderson, K., Gallo, P., Collins, S. (2006). Sample size reestimation: a review and recommendations. Drug Information Journal 40:475-484.
3. Church, J. D., Harris, B. (1970). The estimation of reliability from stress-strength relationships. Technometrics 12:49-54.
4. Cui, L., Hung, H. M. J., Wang, S. J. (1999). Modification of sample size in group sequential trials. Biometrics 12:853-857.
5. Enis, P., Geisser, S. (1971). Estimation of the probability that Y < X. Journal of American Statistical Association 66:162-168.
6. Friede, T., Kieser, M. (2004). Sample size recalculation for binary data in internal pilot study designs. Pharmaceutical Statistics 3:269-279.
7. Hsiao, C. F., Hsu, Y. Y., Tsou, H. H., Liu, J. P. (2007). Use of prior information for Bayesian evaluation of bridging studies. Journal of Biopharmaceutical Statistics 17:109-121.
8. Hung, H. M. J., Cui, L., Wang, S. J., Lawrence, J. (2005). Adaptive statistical analysis following sample size modification based on interim review of effect size. Journal of Biopharmaceutical Statistics 15:693-706.
9. International Conference on Harmonisation. (1998). Tripartite guidance E5, Ethnic factors in the acceptability of foreign data. Federal Register 83: 31790-31796.
10. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. (2006). Q&A for the ICH E5 Guldeline on Ethnic Factors in the Acceptability of Foreign Data. Available at: http:// www.ich.org/LOB/media/MEDIA 1194.pdf.
11. Kawai, N., Stein, C., Komiyama O., Li, Y. (2008). An approach to rationalize partitioning sample size into individual regions in a multiregional trial. Drug Information Journal 42:139-147.
12. Lan, G. K. K., Soo, Y. W., Siu, C. T., Wang, M. (2005). The use of weighted Z-tests in medical research. Journal of Biopharmaceutical Statistics 15(4):625-639.
13. Liu, J. P., Hsiao, C. F., Hsueh, H. M. (2002). Bayesian approach to evaluation of bridging studies. Journal of Biopharmaceutical Statistics 12:401-408.
14. Liu, J. P., Hsueh, H. M., Chen, J. J. (2002). Sample size requirement for evaluation of bridging evidence. Biometrical Journal 44:969-981.
15. Liu, Q., Chi, G. Y. H. (2001). On sample size and inference for two-stage adaptive designs. Biometrics 57:172-177.
16. Ministry of Health, Labor, and Welfare of Japan. (2007). Basic Principles on Global Clinical Trials. Tokyo: MHLW.
17. Posch, M., Bauer, P. (1999). Adaptive two-stage designs and the conditional error function. Biometrical Journal 41:689-696.
18. Proschan, M. A. (2005). Two-stage sample size re-estimation based on a nuisance parameter: a review. Journal of Biopharmaceutical Statistics 15:539-574.
19. Proschan, M. A., Hunsberger, S. A. (1995). Designed extension of studies based on conditional power. Biometrics 51:1315-1324.
20. Shih, W. J. (2001). Clinical trials for drug registration in Asian-Pacific countries: Proposal for a new paradigm from a statistical perspective. Controlled Clinical Trials 22:357-366.
21. Shih, W. J. (2006). Group sequential, sample size re-estimation and two-stage adaptive designs in clinical trials: a comparison. Statistics in Medicine 25:933-941.